SOURCE: Market Foundations Inc.

February 07, 2012 09:00 ET

Perception, Opportunity in Volatility - Research & Analysis on Human Genome Sciences and Merck & Co., Inc.

HONG KONG--(Marketwire - Feb 7, 2012) - This morning, announced new reports highlighting Human Genome Sciences (NASDAQ: HGSI) and Merck & Co., Inc. (NYSE: MRK). Free research downloads are available at

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experienced in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Market Foundations is releasing new coverage on Human Genome Sciences for its current position within the healthcare industry. Human Genome Sciences, Inc. (HGS) is a biopharmaceutical company. The Company's products are BENLYSTA (belimumab) for systemic lupus erythematosus (SLE) and raxibacumab for inhalation anthrax. GlaxoSmithKline (GSK) is a HGS partner in the co-development and commercialization of BENLYSTA. The full research report on Human Genome Sciences (NASDAQ: HGSI) is available here:

Market Foundations has released research on Merck & Co., Inc. for its changing role within the healthcare industry. Merck & Co., Inc. (Merck) is a global health care company. Merck delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates in four segments: Pharmaceutical, Animal Health, Consumer Care and Alliances. The full research report on Merck & Co., Inc. (NYSE: MRK) is available here:

About Market Foundations
By providing members with financial information services, we provide the foundation investors need to build investing intelligence. The difference between consistently making good investments or bad investments is nothing more than the right information at the right time.

Contact Information